13.13
Electroconvulsive therapy, or ECT, commonly known as shock therapy, originated from Hippocrates' observations in ancient Greece, who noted that malaria-induced convulsions sometimes alleviated mental illnesses.
In 1938, Ugo Cerletti, an Italian neurologist, developed the modern method of inducing controlled seizures with electric shocks.
ECT is used to treat severe depression, especially drug-resistant cases, using a brief electric pulse to induce a controlled seizure lasting about one minute under anesthesia and muscle relaxants, ensuring minimal discomfort during the electric pulse and preventing bodily convulsions.
Older bilateral ECT, which placed electrodes on both sides of the head, caused more memory problems. Unilateral ECT, which places one electrode on the right side and the other on top, reduces the risk of memory loss.
Over 70% of patients showed improvement within two to four weeks, offering rapid, life-saving relief for those with acute depression who are at high suicide risk.
ECT is effective but controversial due to memory loss, cognitive side effects, and its perceived barbarity.
Additionally, relapse into depression remains a concern for some patients.
電気けいれん療法(ECT)またはショック療法は、重度で治療に抵抗性のあるうつ病に対する重要な生物医学的介入です。その起源は、マラリア誘発性のけいれんが精神疾患を軽減するというヒポクラテスの観察にまで遡りますが、現代の ECT は、以前のより原始的な用途から大きく進化しています。1938 年にウーゴ・…
著作権 © 2026 MyJoVE Corporation. 無断転載を禁じます。